US Representative
Blaine Luetkemeyer 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 3)
Legislative Session
Co-Sponsor of Legislation
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1817
Introduced
3/27/23
Refer
3/27/23
Preventing Racial Profiling in Lending Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2365
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
Report Pass
12/6/23
Engrossed
12/14/23
Enrolled
6/28/24
Passed
7/2/24
Chaptered
7/2/24
Passed
7/2/24
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2433
Introduced
3/30/23
Refer
3/30/23
Fairness for Rural Teaching Hospitals Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2434
Introduced
3/30/23
Refer
3/30/23
Refer
4/7/23
Next Generation Fuels Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2440
Introduced
3/30/23
Refer
3/30/23
Covenant School Heroes Congressional Gold Medal Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2474
Introduced
4/3/23
Refer
4/3/23
Refer
4/14/23
Strengthening Medicare for Patients and Providers Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2489
Introduced
4/6/23
Refer
4/6/23
CFPB Dual Mandate and Economic Analysis Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2490
Introduced
4/6/23
Refer
4/6/23
CFPB Whistleblower Incentives and Protection Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2539
Introduced
4/6/23
Refer
4/6/23
New Markets Tax Credit Extension Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB26
Introduced
1/9/23
Refer
1/9/23
Engrossed
1/23/23
Born-Alive Abortion Survivors Protection Act This bill establishes requirements for the degree of care a health care practitioner must provide in the case of a child born alive following an abortion or attempted abortion. Specifically, a health care practitioner who is present must (1) exercise the same degree of care as would reasonably be provided to any other child born alive at the same gestational age, and (2) ensure the child is immediately admitted to a hospital. Additionally, a health care practitioner or other employee who has knowledge of a failure to comply with the degree-of-care requirements must immediately report such failure to law enforcement. A health care practitioner who fails to provide the required degree of care, or a health care practitioner or other employee who fails to report such failure, is subject to criminal penalties—a fine, up to five years in prison, or both. An individual who intentionally kills or attempts to kill a child born alive is subject to prosecution for murder. The bill bars the criminal prosecution of a mother of a child born alive under this bill and allows her to bring a civil action against a health care practitioner or other employee for violations.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2630
Introduced
4/13/23
Refer
4/13/23
Safe Step Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2673
Introduced
4/18/23
Refer
4/18/23
American Innovation and R&D Competitiveness Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2743
Introduced
4/20/23
Refer
4/20/23
Fair Access to Banking Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB277
Introduced
1/11/23
Refer
1/11/23
Report Pass
5/24/23
Engrossed
6/20/23
Regulations from the Executive in Need of Scrutiny Act of 2023 This bill revises provisions relating to congressional review of agency rulemaking. Specifically, the bill establishes a congressional approval process for a major rule. A major rule may only take effect if Congress approves of the rule. A major rule is a rule that has resulted in or is likely to result in (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices for consumers, individual industries, government agencies, or geographic regions; or (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete with foreign-based enterprises. The bill generally preserves the current congressional review process for a nonmajor rule.
Primary Sponsor of Legislation
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2603
Introduced
4/13/23
Refer
4/13/23
To require the Securities and Exchange Commission to revise certain thresholds related to smaller reporting companies, accelerated filers, and large accelerated filers, and for other purposes.